Search All Resources
Understanding the New Changes to 42 CFR Part 2 (CoE-PHI)
Type: Video
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Virology Harm Reduction Virtual Care Implementation Journey to Health
Webinar to help providers understand the changes to 42 CFR Part 2 and SAMHSA guidance regarding patient privacy.
Date added: 07/24/21
Top Seven Telehealth Privacy Considerations for SUD Treatment and Recovery Support Providers (CoE-PHI)
Type: Website
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Virtual Care Implementation Virology Journey to Health
8-Part podcast series focusing on tips and resources for SUD and recovery support treatment providers on the topic of maintaining patient privacy while providing telehealth services.
Date added: 07/24/21
Telehealth and Privacy: Tips and Guidance for SUD and Mental Health Treatment Providers (CeE-PHI)
Type: Handouts
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Virtual Care Implementation Virology Journey to Health
Guidance for providers to help maintain patient privacy while providing telehealth services.
Date added: 07/24/21
Tribal Opioid Response National Strategic Agenda (NPAIHB)
Type: Download
Audience: Clinical
Program: Substance Use Disorder Harm Reduction Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
To assist tribes in successfully addressing the opioid epidemic, the Northwest Portland Area Indian Health Board, along with partners, developed this strategic agenda. Recommendations are based on input from tribal policymakers, service providers, and individuals with opioid use disorder (OUD).
Date added: 07/24/21
Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use (HHS)
Type: Website
Audience: Clinical
Guidance for providers when changing a patientâs chronic pain therapy.
Date added: 07/24/21
Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants (SAMHSA)
Type: Website
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants.
Date added: 07/24/21
Tribal MAT ECHO Clinics (OASIS-TTA)
Monthly 1-hour virtual clinics designed to support health care providers in Indian Country to deliver MAT. Sessions begin with a didactic presentation on a topic relevant to MAT care delivery and feature a de-identified case presentation and facilitated discussion. CEs ...
Date added: 07/24/21
Steps to Obtain your MAT Waiver (PCSS)
Type: Website
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Harm Reduction
Guidance for obtaining waiver (required by the DEA) for the use of buprenorphine in medication-assisted treatment.
Date added: 07/24/21
Practitioner Training (SAMHSA)
Type: Website
Audience: Clinical
Program: Substance Use Disorder Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams Journey to Health
Tools, training, and technical assistance for practitioners in the field of substance use and mental health disorders.
Date added: 07/24/21
Rx Pain Medications, Know the Options, Get the Facts – Prescription Drug Monitoring Programs (SAMHSA)
Type: Website
Audience: Clinical
Fact sheet that focuses on how Prescription Drug Monitoring Programs (PDMPs) help health providers better serve their patients' needs and promote safety.
Date added: 07/24/21
